Glenmark Pharmaceuticals has launched the world’s first nebulized triple therapy for COPD, marking a major step forward in respiratory care. The new products — Nebzmart GFB Smartules and Glenmark Airz FB Smartules — blend Glycopyrronium...
Apollo Hospitals opened its latest healthcare facility in Swargate, Pune, on Monday, marking its third hospital in Maharashtra and further expanding its presence in western India
Alkem Laboratories Ltd has introduced DSS, the original De Simone formulation probiotic mixture in India, aimed at restoring gut microbiota equilibrium and addressing several gut-related health issues.
Eli Lilly has become the first drugmaker to reach a $1?trillion market valuation, driven by soaring demand for its weight?loss and diabetes drugs. This ascension is indicative of how the weight-loss drug market, which was initially a niche, has...
Alkem Laboratories has introduced the original De Simone formulation to India, marking a strong move into the country’s fast-rising gut-health market. The launch comes at a time when digestive disorders are climbing and consumer awareness around...
HRV Pharma has announced a significant CDMO partnership with MetroChem API, marking one of India’s standout moves in advanced API development. Revealed today, the multi-year agreement positions HRV Pharma’s Virtual API platform alongside...
Kailash Hospital & Heart Institute in Noida has been awarded the NABH Digital Health Gold Certification by the National Accreditation Board for Hospitals & Healthcare Providers, placing it among the country’s leading digital healthcare institutions
.png)
Zydus Lifesciences and SIG have introduced a major advancement in pharmaceutical packaging with a single-serve format for liquid cough and cold medication. The launch leverages SIG’s tethered spout solution SIG StrawCap 30 Linked and Motion...
.png)
AstraZeneca Pharma India and Sun Pharmaceutical Industries have struck a second brand partnership to broaden access to sodium zirconium cyclosilicate (SZC), a critical therapy for hyperkalaemia, across India. Under this deal, AstraZeneca will...
Following the historic approval granted in August 2025 by India’s Central Drugs Standard Control Organization (CDSCO), Shilpa Medicare has launched NODUCA (Nor Ursodeoxycholic Acid, or norUDCA), the first medication of its kind to be introduced in
, CDSCO.jpg)